CNCI and SS Innovations International Showcased the Future of Robotic Surgery in Cancer Care on World Cancer Day 2026…
Kolkata, February 4, 2026, On the occasion of World Cancer Day 2026, Chittaranjan National Cancer Institute (CNCI), in association with SS Innovations International, hosted a press conference at its Kolkata campus, highlighting the evolving role of robotic-assisted surgery in cancer care. The event brought together leading oncologists, surgeons, and technology experts to discuss how advanced surgical robotics is contributing to improved cancer treatment outcomes in India.
As one of India’s premier cancer care institutions under the Ministry of Health & Family Welfare, Government of India, CNCI continues to strengthen its focus on adopting advanced medical technologies that enhance patient care. During the press conference, discussions centred around the clinical impact of robotic-assisted surgeries, CNCI’s future roadmap in advanced cancer treatment, and the growing role of indigenous robotic platforms in strengthening the country’s healthcare ecosystem.
Speaking on the occasion, Dr Jayanta Chakraborty, Director, CNCI, said, “For every cancer patient, timely and precise treatment can make a real difference to both outcomes and quality of life. At CNCI, our effort has always been to adopt technologies that genuinely support doctors and benefit patients. Robotic-assisted surgery allows surgeons to operate with greater accuracy while reducing surgical stress for patients. On World Cancer Day, this collaboration reflects our commitment to continuously evolve cancer care in ways that are meaningful, practical, and patient-centric.”
The discussions also underscored the increasing importance of Made-in-India medical technologies in addressing long-standing challenges related to access to advanced healthcare, particularly beyond metropolitan centres.
Sharing his perspective, Dr. Sudhir Srivastava, Founder, Chairman & CEO, SS Innovations International Inc., said, “When we speak about advancing cancer care in India, the conversation must go beyond innovation to include access. For a long time, advanced surgical technologies were available only to a limited few in large cities. Our vision at SS Innovations has been to change that by building affordable, Made-in-India robotic systems that can be adopted widely.”
The press conference was addressed by senior leadership and surgeons from CNCI, including Dr Sankar Sengupta, Medical Superintendent, along with senior surgical oncologists Dr Sagar Sen, Dr Nanda, Dr Dipanwita Banerjee, and Dr Sandip Mondal, who shared insights on clinical outcomes, patient benefits, and the institute’s leadership in adopting advanced surgical innovations. Experts from the SSII Mantra Robotic Platform also highlighted the role of indigenous robotic technology in advancing cancer care in India.
About SS Innovations International, Inc:
SS Innovations International, Inc. (Nasdaq: SSII) develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The Company’s product range includes its proprietary “SSII Mantra” surgical robotic system and its comprehensive suite of “SSII Mudra” surgical instruments, which support a variety of surgical procedures, including robotic cardiac surgery.
About SSII Mantra:
The SSII Mantra Surgical Robotic System, by SS Innovations International Inc., is a modular multi-arm system with many advanced technology features. It allows for the use of 3-5 robotic arms, has an open-faced ergonomic Surgeon Command Centre, a 32-inch 3D 4K monitor, a 23-inch 2D Touch panel monitor for all patient-related information display, a virtual real-time image of the robotic Patient Side Arm Carts, and the ability for superimposition of 3D models of diagnostic imaging. The Vision Cart gives the table-side team the same magnified 3D 4K view as the Surgeon to provide better safety and efficiency. The modular robotic arms give flexibility in positioning and the number of arms to be used. This allows for collision-free conduct of surgical operations. There are over 40 different types of robotic endo-surgical instruments that can be used for different specialties including Cardiac Surgery. The learning curve is short due to its very thoughtful and ergonomic design and user-friendly features.
